RE-BVS – Piemonte Repository

Sfoglia per AUTORE
YANG J
Collezione AOU San Luigi di Orbassano

Items : 9

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. in Lancet (London, England) / Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14.

2024
AOU San Luigi di Orbassano

Spicer JD; Garassino MC; Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Arunachalam A; Keller SM; Samkari A; Gao S;

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 1;41(31):4852-4863. doi: 10.1200/JCO.23.01361. Epub 2023 Sep 11.

2023
AOU San Luigi di Orbassano

Goto K; Goto Y; Kubo T; Ninomiya K; Kim SW; Planchard D; Ahn MJ; Smit EF; de Langen AJ; Pérol M; Pons-Tostivint E; Novello S; Hayashi H; Shimizu J; Kim DW; Kuo CH; Yang JC; Pereira K; Cheng FC; Taguchi A; Cheng Y; Feng W; Tsuchihashi Z; Jänne PA;

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3.

2023
AOU San Luigi di Orbassano

Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Gao S; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Keller SM; Samkari A; Spicer JD;

Expert consensus on resection of chest wall tumors and chest wall reconstruction. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Nov;10(11):4057-4083. doi: 10.21037/tlcr-21-935.

2021
AOU San Luigi di Orbassano

Wang L; Yan X; Zhao J; Chen C; Chen C; Chen J; Chen KN; Cao T; Chen MW; Duan H; Fan J; Fu J; Gao S; Guo H; Guo S; Guo W; Han Y; Jiang GN; Jiang H; Jiao WJ; Kang M; Leng X; Li HC; Li J; Li J; Li SM; Li S; Li Z; Li Z; et alii...

Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study. in JTO clinical and research reports / JTO Clin Res Rep. 2020 Oct 26;2(2):100114. doi: 10.1016/j.jtocrr.2020.100114. eCollection 2021 Feb.

2021
AOU San Luigi di Orbassano

Yang JC; Reckamp KL; Kim YC; Novello S; Smit EF; Lee JS; Su WC; Akerley WL; Blakely CM; Groen HJM; Bazhenova L; Carcereny Costa E; Chiari R; Hsia TC; Golsorkhi T; Despain D; Shih D; Popat S; Wakelee H;

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.

2020
AOU San Luigi di Orbassano

Novello S; Rubio-Viqueira B; Garon EB; Reck M; Jennens RR; Grossi F; Peled N; Bischoff HG; Cheng SY; Powell SF; Clingan P; Hochmair MJ; Hui R; Dómine M; Felip E; Esteban E; Speranza G; Gadgeel S; Rodríguez-Abreu D; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC;

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.

2018
AOU San Luigi di Orbassano

Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC; et alii...

Scientific Advances in Thoracic Oncology 2016. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1.

2017
AOU San Luigi di Orbassano

Soo RA; Stone ECA; Cummings KM; Jett JR; Field JK; Groen HJM; Mulshine JL; Yatabe Y; Bubendorf L; Dacic S; Rami-Porta R; Detterbeck FC; Lim E; Asamura H; Donington J; Wakelee HA; Wu YL; Higgins K; Senan S; Solomon B; Kim DW; Johnson M; Yang JCH; Sequist LV; Shaw AT; Ahn MJ; Costa DB; Patel JD; Horn L; et alii...

TIGER-3: A phase 3 multinational open-label randomized study of rociletinib vs investigator-choice chemotherapy in patients (pts) with epidermal growth factor receptor mutantpositive (EGFRm) non-small cell lung cancer (NSCLC) progressing on prior EGFR tyrosine kinase inhibitor (TKI) therapy and doublet chemotherapy in Journal of Clinical Oncology

2016
AOU San Luigi di Orbassano

Yang JC-H; Popat S; Novello S; Groen HJM; Perol M; Felip E; Griesinger F; Reckamp KL; Lee J-S; Smit EF; Blakely CM; Akerley WL; Kim Y-C; Bazhenova L; Califano R; Delmar Hall R; Georgiou P; Isaacson JD; Golsorkhi T; Wakelee HA;